Glaxo customized "red wine" drug potent in mice
LONDON (Reuters) - A drug in development that mimics a health-boosting compound found in red wine may be a powerful weapon in the fight against obesity and diabetes, researchers said on Tuesday.
A study of mice showed that the GlaxoSmithKline drug SRT1720 was about a thousand times more potent than resveratrol in activating an enzyme that helped the animals burn more energy and lower their insulin and glucose levels.
Keywords: compound, diabetes, Drug, energy, glaxo, glaxosmithkline, glucose, glucose level, glucose levels, health, help, insulin, men, mice, obesity, research, researchers, study